TrialThe Journal of infectious diseases2006

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.

Andrew T Catanzaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.